Answers are grounded in this paper and cite their sources.
INTRODUCTION: Chemical exchange saturation transfer (CEST) has been demonstrated to provide a noninvasive opportunity to image gliomas. Preclinical ultrahigh-field MRI studies have shown the value of the 2 ppm pool; however, in vivo studies in glioma patients are currently lacking. This study aimed to explore the 7 T MRI CEST contrast of the 2 ppm in gliomas and the tumor's different components. METHODS: Twenty-one glioma patients treated at two tertiary referral centers for brain tumors in the Netherlands were scanned. Regions of interest were defined as contrast-enhancing (CE-lesion), nonenhancing (NE-lesion) tumor, and the contralateral normal-appearing white matter (CL NAWM). Magnetization transfer ratio asymmetry (MTRasym), Lorentzian difference (LD), spillover and magnetization transfer-corrected inverse difference (REX), and relaxation-compensated (AREX) were calculated for all regions of interest. RESULTS: The 2 ppm CEST pool signal between tumor regions and normal-appearing tissue was found to be significantly different for all four CEST quantification methods (MTRasym p = 0.001; LD p < 0.001; REX p = 0.008; AREX p = 0.001). The CE and NE lesions showed significantly different 2 ppm pool CEST MTRasym (p = 0.034) and LD (p = 0.052). Significantly different 2 ppm CEST REX (p = 0.005) and AREX (p = 0.001) were found between the CL NAWM and the NE lesions. CONCLUSIONS: CEST 2 ppm pool contrast was distinctive between normal-appearing white matter, enhancing and nonenhancing tumor lesions, independently of the metric used. These findings suggest that the CEST pool at 2 ppm provides a valuable noninvasive contrast for imaging gliomas.
No takes yet. Share an insight, caveat, or question.
Schmitz‐Abecassis et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: